Article
Nebu~Flow welcomes Michael Khan to the Board of Directors
We are pleased to announce that Dr. Mike Khan has joined our Board of Directors. With over 25 years of leadership experience in R&D, Michael Khan brings extensive expertise across preclinical, translational, and clinical development to Nebu~Flow . He combines a deep understanding of drug development and delivery with hands-on clinical experience, and senior roles within the NHS, including commissioning and setting of National clinical guidelines.
Latest news
Winner of Start-up initiatives award CPHI Pharma 2024
We are honoured to be the winner of Start-up initiatives award from CPHI Pharma Award. This is great recognition of our works to transform respiratory drug delivery. Thanks to the judges, CPHI and also our great team at Nebu~Flow .
Read more
Nebu~Flow welcomes Andrea Cusack as Chief Executive Officer
We are thrilled to introduce Andrea Cusack as the CEO of Nebu~Flow ! With over 25 years of experience in commercial strategy, M&A, and fundraising in the Life Sciences sector, Andrea is a fantastic addition to guide us towards our vision and drive business success.
Read more
Nebu-Flow secures £4.7m to accelerate next generation respiratory pharmaceuticals
Nebu-Flow secures £4.7 million investment to accelerate next-generation respiratory pharmaceuticals, poised to revolutionize drug delivery for respiratory disorders.
Read more
Nebu~Flow Wins Prestigious Institute of Physics Award
“At Nebu~Flow, we are proud to lead the charge in reshaping the future of inhalation drug delivery to treat respiratory disorders,” remarked chairman Dr John Pritchard.
Read more
